Subscribe to Newsletter

John C. Martin

The Power List 2017 – Business Captains

John C. Martin

Executive Chairman, Gilead Sciences

John was appointed Executive Chairman of Gilead in March 2016, after a 20-year stint as the company’s CEO. John led the team that developed the blockbuster drug, Sovaldi (sofosbuvir), for the treatment of hepatitis C. He is due to receive the 2017 Biotechnology Heritage Award in June 2017.

Part of the Power List 2017

Our Top 100 into 4 categories

Go to The Power List 2017

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine